VX-668
VX22-668-001
Phase 1 small_molecule completed
Quick answer
VX-668 for Alpha-1 Antitrypsin Deficiency is a Phase 1 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Alpha-1 Antitrypsin Deficiency
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed